Literature DB >> 2397017

Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization.

R R Caspi1, C C Chan, W C Leake, M Higuchi, B Wiggert, G J Chader.   

Abstract

Experimental autoimmune uveoretinitis (EAU) in the mouse is a recently developed model of ocular autoimmunity. Dependence of disease induction on qualitative and quantitative parameters of immunization was studied in B10.A mice immunized with interphotoreceptor retinoid-binding protein (IRBP). It was found that use of Bordetella pertussis adjuvant as well as its mode of preparation was of critical importance for disease induction; no disease was induced if pertussis adjuvant was omitted. The minimal effective protocol for EAU induction when the vaccine form of B. pertussis adjuvant was used consisted of pretreatment with cyclophosphamide, two divided doses of IRBP in complete Freund's adjuvant (CFA), and two divided doses of B. pertussis vaccine. Any reduction in the immunization schedule resulted in reduced incidence of disease. In contrast, substituting purified B. pertussis toxin (PTX) for the vaccine allowed reduction of the immunization schedule to a single dose of IRBP in CFA and omission of the cyclophosphamide pretreatment. Severity and incidence of disease could be quantitatively controlled by varying the respective doses of IRBP and PTX. In addition, a chronic or an acute clinical course of EAU could be obtained by using either a low-dose or a high-dose immunization, respectively. Establishment of a single dose induction protocol and the quantitation of the immunopathogenic response as a function of the variables of immunization lay the foundation for the further development and utilization of this promising model of ocular autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397017     DOI: 10.1016/0896-8411(90)90143-g

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  11 in total

Review 1.  Immune mechanisms in uveitis.

Authors:  R R Caspi
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy.

Authors:  Takashi Yamashita; Yoshihide Asano; Ryosuke Saigusa; Takashi Taniguchi; Megumi Hirabayashi; Takuya Miyagawa; Kouki Nakamura; Shunsuke Miura; Ayumi Yoshizaki; Maria Trojanowska; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2018-11-30       Impact factor: 8.551

3.  Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.

Authors:  Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

4.  Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina.

Authors:  Neal D Heuss; Ute Lehmann; Christopher C Norbury; Scott W McPherson; Dale S Gregerson
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

5.  A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration.

Authors:  Joe G Hollyfield; Victor L Perez; Robert G Salomon
Journal:  Mol Neurobiol       Date:  2010-03-12       Impact factor: 5.590

6.  A suppressive oligodeoxynucleotide inhibits ocular inflammation.

Authors:  C Fujimoto; D M Klinman; G Shi; H Yin; B P Vistica; J D Lovaas; E F Wawrousek; T Igarashi; C-C Chan; I Gery
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

7.  Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene.

Authors:  Y De Kozak; B Thillaye-Goldenberg; M-C Naud; A Vianna Da Costa; C Auriault; C Verwaerde
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

8.  Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.

Authors:  Jun Chen; Haohua Qian; Reiko Horai; Chi-Chao Chan; Yishay Falick; Rachel R Caspi
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

9.  Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.

Authors:  Pedro Henrique Papotto; Eliana Blini Marengo; Luiz Roberto Sardinha; Karina Inácio Carvalho; Ana Eduarda Zulim de Carvalho; Sheyla Castillo-Mendez; Carina Calixto Jank; Bernard Vanhove; Anna Carla Goldberg; Luiz Vicente Rizzo
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

10.  Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.

Authors:  Linhua Zhang; Yue Li; Chao Zhang; Yusheng Wang; Cunxian Song
Journal:  Int J Nanomedicine       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.